Yardley, PA, United States of America

Joseph LaMorte

This inventor holds 1 USPTO granted patent. Top assignee: Villanova University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph LaMorte. Retrieved from https://idiyas.com/inventor/joseph-lamorte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph LaMorte: Innovator in Pharmaceutical Composition

Introduction

Joseph LaMorte is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at combating cancer. His innovative approach combines the use of oxidizable biphenol and manganese porphyrin to create effective treatments.

Latest Patents

LaMorte holds a patent for a pharmaceutical composition comprising oxidizable biphenol and manganese porphyrin, along with a method of using the same. This composition is designed to kill cancer cells, providing a promising avenue for cancer treatment. The formulation can be administered in a one-part or two-part dosage form, allowing for flexibility in treatment protocols.

Career Highlights

Joseph LaMorte is affiliated with Villanova University, where he continues to advance his research in pharmaceutical sciences. His work is characterized by a commitment to developing innovative solutions for serious health challenges, particularly in oncology.

Collaborations

LaMorte collaborates with esteemed colleagues such as Aimee Eggler and Sandra Tamarin, contributing to a dynamic research environment focused on pharmaceutical advancements.

Conclusion

Joseph LaMorte's contributions to pharmaceutical innovation highlight the potential of combining different chemical compounds to create effective cancer treatments. His work exemplifies the importance of research and collaboration in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…